title: Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration.
abstract: Mild constitutive hyperbilirubinemia is associated with a reduced risk of cardiovascular diseases, diabetes, and cancer. Since these pathologies are associated with aging, inflammation, and oxidative stress, we investigated whether hyperbilirubinemia interferes with ROS homeostasis in cell cultures and with inflammation, senescence, and mitochondrial dysfunction in aged rats. Human embryonic kidney cells and rat primary fibroblasts showed a dose-dependent decrease in the ratio of oxidized/reduced glutathione, intracellular H2O2 levels, and mitochondrial ROS production, with increasing bilirubin concentrations in the culture media. Compared to their normobilirubinemic siblings, aged hyperbilirubinemic Gunn rats showed significantly smaller amounts of visceral fat, better glucose tolerance, and decreased serum levels of proinflammatory cytokines TNFα, IL-1β, and IL-18. Simultaneously, livers from Gunn rats showed decreased expression of senescence markers and cell cycle inhibitors p21 and p16. Mitochondria from aged Gunn rats showed higher respiration and lower H2O2 production compared to controls. In conclusion, we demonstrated that mildly elevated serum bilirubin is generally associated with attenuation of oxidative stress and with better anthropometric parameters, decreased inflammatory status, increased glucose tolerance, fewer signs of cellular senescence, and enhanced mitochondrial function in aged rats.
authors.affiliation: Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.
authors.forename: Jaroslav
authors.initials: J
authors.lastname: Zelenka
authors.affiliation: Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic; Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Na Bojišti 3, 128 08 Prague, Czech Republic.
authors.forename: Aleš
authors.identifier: 0000-0002-1285-6928
authors.initials: A
authors.lastname: Dvořák
authors.affiliation: Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic.
authors.forename: Lukáš
authors.identifier: 0000-0001-7417-2620
authors.initials: L
authors.lastname: Alán
authors.affiliation: Institute of Biophysics, 1st Faculty of Medicine, Charles University in Prague, Salmovská 1, 128 08 Prague, Czech Republic.
authors.forename: Marie
authors.initials: M
authors.lastname: Zadinová
authors.affiliation: Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Na Bojišti 3, 128 08 Prague, Czech Republic; Institute of Endocrinology, Národní 8, 116 94 Prague, Czech Republic.
authors.forename: Martin
authors.initials: M
authors.lastname: Haluzík
authors.affiliation: Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Na Bojišti 3, 128 08 Prague, Czech Republic; 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 128 08 Prague, Czech Republic.
authors.forename: Libor
authors.identifier: 0000-0002-5318-0151
authors.initials: L
authors.lastname: Vítek
mesh_terms: D000375:Aging / Q000473:pathology*; D000818:Animals; D001663:Bilirubin / Q000097:blood; D002478:Cells, Cultured; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D006932:Hyperbilirubinemia / Q000097:blood / Q000473:pathology*; D007249:Inflammation / Q000150:complications* / Q000473:pathology*; D042541:Intracellular Space / Q000378:metabolism; D008659:Metabolic Diseases / Q000150:complications* / Q000473:pathology*; D008928:Mitochondria / Q000378:metabolism; D011911:Rats, Gunn; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D017382:Reactive Oxygen Species; D001663:Bilirubin